Disease/Infection News

RSS

Omnyx initiates research testing of digital pathology platform

GE Healthcare and UPMC announced today that their imaging joint venture, Omnyx, is initiating clinical research testing of a breakthrough digital pathology platform that is expected to help transform the 125-year-old practice of pathologists using glass slides.

28 Oct 2010

Reuters examines development progress of microbicide gel to prevent HIV

Reuters reports that the developers of a vaginal microbicide gel containing the antiretroviral tenofovir, which has been found to reduce "HIV infections in women by 39 percent," said the FDA last week granted fast-track approval designation to the gel.

28 Oct 2010

Flu deaths analyzed for future lessons

A new report has looked at all of England’s swine flu deaths in children under 18 during the 2009 pandemic. Researchers found that there was a higher risk of dying from the influenza A H1N1 strain of flu among certain groups of children, such as those with pre-existing conditions and those of a Pakistani or Bangladeshi background. However it was unclear why.

27 Oct 2010

Cholera epidemic and political violence dogs upcoming Haiti elections

With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.

27 Oct 2010

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

Vical Incorporated today announced that the company's Vice President of Clinical Development, Richard T. Kenney, M.D., is presenting preclinical results from the company's herpes simplex type 2 (HSV-2) vaccine program in a poster session Friday morning at the Keystone Symposium on Immunological Mechanisms of Vaccination (Seattle, October 27 – November 1).

27 Oct 2010

BioSilta releases EnPresso tablet that regulates protein production in recombinant bacteria

BioSilta announces the release of the EnPresso Tablet Cultivation Set, a tabletised form of the patented EnBase technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density.

27 Oct 2010

Expert shares information on detoxification to promote better health

Cold and flu season is right around the corner, so it's time to start taking the steps to keep your body protected. Natural chelation and detoxification expert, Dr. Isaac Eliaz is re-shaping the way we look at detox methods by examining ways to enhance your body's natural defenses and prevent germs from attacking. Dr. Eliaz has profound information on various modalities of detoxification, including effective detox diets, integrative supplement formulas, lifestyle modifications, and detoxification therapies.

27 Oct 2010

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

27 Oct 2010

Halting mosquito surveillance can increase management costs of epidemics 300 times

Cutting surveillance for mosquito-borne diseases would likely translate into an exponential increase in both the number of human cases and the health costs when a disease outbreak occurs, according to an analysis by Emory University.

27 Oct 2010

New International malaria research consortium to develop novel classes of antimalarials

Research teams from three academic institutions and two private sector companies on two continents have come together to form the International malaria research consortium for the development of novel classes of antimalarials. This bold initiative will develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.

27 Oct 2010

Study: lncRNA are involved in host response to viral infection

Scientists have demonstrated for the first time that a certain class of RNA (known as long non-protein-coding RNA [lncRNA]) are involved in the host response to viral infection. These findings, published today in the online journal mBio-, could greatly change the way scientists look at the body's response to viral infection.

27 Oct 2010

B.C. pharmacists are authorized to administer flu shots

As British Columbians get ready for flu season, the BC Pharmacy Association is reminding patients that they can get their seasonal vaccination from their pharmacist.

27 Oct 2010

Older adults with severe sepsis at higher risk for cognitive impairment

Older adults who survive severe sepsis are at higher risk for long-term cognitive impairment and physical limitations than those hospitalized for other reasons, according to researchers from the University of Michigan Health System.

27 Oct 2010

University of Padua Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize

Frankfurt am Main. The chemist and biologist Professor Cesare Montecucco, 62, of the Department of Biomedical Research at the University of Padua, Italy, has won the 100,000 euro Paul Ehrlich and Ludwig Darmstaedter Prize 2011 for his contribution to research in the field of bacterial diseases, including tetanus, botulism, anthrax and Helicobacter pylori associated diseases.

27 Oct 2010

Sex hormones behind increased risk of destructive periodontitis in men

Sex hormones may be the biological reason why men are at greater risk than women for destructive periodontitis, an infection of the gums, according to researchers at the University of Maryland Dental School.

27 Oct 2010

ECSA forum kicks off Monday with discussion on effects of funding, health worker shortages on MDGS

Officially opening the East, Central and Southern Africa (ECSA) forum on best practices and joint consultative meeting on Monday, [Zimbabwe Minister of Health and Child Welfare Henry] Madzorera said the shortage of health workers and the growing burden of communicable and non-communicable diseases had slowed down progress toward achieving the U.N. Millennium Development Goals (MDGs), NewsDay reports.

27 Oct 2010

Reuters examines how harm reduction policies in Switzerland could serve as model for reducing spread of HIV/AIDS among IDUs

Switzerland's innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime rates and should serve as a global model, health experts said on Monday, Reuters reports in an article that examines the outcomes of drug policy reform in the country

27 Oct 2010

Bivalent oral polio vaccine produces better immune response than more commonly used trivalent vaccine, study says

The bivalent oral polio vaccine (bOPV) was found to induce a significantly higher immune response than the existing trivalent oral polio vaccine (tOPV), according to a study published on Tuesday in the journal Lancet, Reuters reports.

27 Oct 2010

Jamieson releases flu-fighting formula with echinacea

Jamieson Laboratories, Canada's largest manufacturer of advanced natural-health products, announced the release of FluShield™, a clinically proven flu-fighting formula that is made with a patented, next-generation echinacea extract known as LPx3.

27 Oct 2010

Oncolytics presents REO 013 clinical trial data for colorectal cancer at International Symposium in Spain

Oncolytics Biotech Inc. announced today that interim data from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases was presented at the International Symposium on Cytotoxic T-lymphocytes (CTL) and Immunostimulation being held in Pamplona, Spain.

27 Oct 2010

Disease/Infection News

Omnyx initiates research testing of digital pathology platform

Reuters examines development progress of microbicide gel to prevent HIV

Flu deaths analyzed for future lessons

Cholera epidemic and political violence dogs upcoming Haiti elections

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

BioSilta releases EnPresso tablet that regulates protein production in recombinant bacteria

Expert shares information on detoxification to promote better health

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

Halting mosquito surveillance can increase management costs of epidemics 300 times

New International malaria research consortium to develop novel classes of antimalarials

Study: lncRNA are involved in host response to viral infection

B.C. pharmacists are authorized to administer flu shots

Older adults with severe sepsis at higher risk for cognitive impairment

University of Padua Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize

Sex hormones behind increased risk of destructive periodontitis in men

ECSA forum kicks off Monday with discussion on effects of funding, health worker shortages on MDGS

Reuters examines how harm reduction policies in Switzerland could serve as model for reducing spread of HIV/AIDS among IDUs

Bivalent oral polio vaccine produces better immune response than more commonly used trivalent vaccine, study says

Jamieson releases flu-fighting formula with echinacea

Oncolytics presents REO 013 clinical trial data for colorectal cancer at International Symposium in Spain

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News